Sharekhan

Camlin Fine Sciences Ltd

Wed 21/05/2025,15:58:47 | NSE : CAMLINFINE

₹ 192.77-1.61 (-0.83%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 195.50

Previous Close

₹ 194.38

Volume

847307

Mkt Cap ( Rs. Cr)

₹3622.56

High

₹ 197.15

Low

₹ 192.00

52 Week High

₹ 204.94

52 Week Low

₹ 83.22

Book Value Per Share

₹ 48.66

Dividend Yield

0.00

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Camlin Fine Sciences Ltd

Your Vote -

Buy

72.28%

Hold

21.78%

Sell

5.94%

72.28%

101 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

192.77

100

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

100

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Camlin Fine Sciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Camlin Fine Sciences - Monitoring Agency Report

    15 May 2025, 5:52PM Report of the Monitoring Agency for the quarter ended March 31, 2025, for Rights Issue.
  • Camlin Fine Sciences - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    15 May 2025, 5:48PM Report of the Monitoring Agency for the quarter ended March 31, 2025, for Rights Issue.
  • Camlin Fine Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    15 May 2025, 5:11PM Camlin Fine Sciences Limited has informed the Exchange about Schedule of meet
  • Camlin Fine Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    15 May 2025, 5:07PM Schedule of Investor Meet
  • Camlin Fine Sciences - Board Meeting Intimation

    14 May 2025, 5:44PM Camlin Fine Sciences Limited has informed the Exchange about Board Meeting to be held on 23-May-2025 to inter-alia consider and approve the Audited Fi
  • Camlin Fine Sciences - Board Meeting Intimation for Consideration And Approval Of The Audited Standalone And Consolidate Fina

    14 May 2025, 5:38PM Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider
  • Camlin Fine Sciences - Fraud/Default/Arrest-XBRL

    2 May 2025, 10:21PM Camlin Fine Sciences Limited has informed the Exchange regarding Disclosure in relation to Fraud
  • Camlin Fine Sciences - Fraud/Default/Arrest

    2 May 2025, 10:04PM Camlin Fine Sciences Limited has informed the Exchange about Fraud/Default/Arrest
  • Camlin Fine Sciences - Reporting Of Fraud By Employee From The Bank Accounts Of Our Wholly Owned Step-Down Subsidiary Viz., B

    2 May 2025, 10:02PM Reporting of Fraud by employee from the bank accounts of our wholly owned step-down subsidiary viz. Britec SA, Guatemala
  • Camlin Fine Sciences - Disclosure under SEBI Takeover Regulations

    30 Apr 2025, 3:05PM Ashish Dandekar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial A
  • Camlin Fine Sciences - Disclosure under SEBI Takeover Regulations

    29 Apr 2025, 3:24PM Infinity Holdings, Infinity Direct Holdings Sidecar I, Infinity Portfolio Holdings, Infinity Direct Holdings has Submitted to the Exchange a copy of D
  • Camlin Fine Sciences - Shareholders meeting

    23 Apr 2025, 7:26PM Camlin Fine Sciences Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy
  • Camlin Fine Sciences - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    23 Apr 2025, 7:19PM Postal Ballot Scrutinizer's Report with Voting Results
  • Camlin Fine Sciences - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    23 Apr 2025, 7:17PM Outcome of Postal Ballot
  • Camlin Fine Sciences has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    18 Apr 2025, 8:10PM As of March 2025, 49.10% is owned by Promoters and 50.90% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 15.58% and Fore
  • Camlin Fine Sciences - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2025, 11:31AM Camlin Fine Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Camlin Fine Sciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2025, 11:26AM Compliance Certificate Under Reg. 74 (5) of SEBI
  • Camlin Fine Sciences - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    26 Mar 2025, 8:50PM CAMLIN FINE SCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfe
  • Camlin Fine Sciences - Appointment

    26 Mar 2025, 8:50PM Camlin Fine Sciences Limited has informed the Exchange regarding Appointment of Mr Pankaj Pawade as SMP of the company w.e.f. May 20, 2025.
  • Camlin Fine Sciences - Announcement under Regulation 30 (LODR)-Change in Management

    26 Mar 2025, 8:48PM Appointment of Mr. Pankaj Pawade - Sr. General Manager
  • Camlin Fine Sciences - Trading Window-XBRL

    26 Mar 2025, 12:40PM Camlin Fine Sciences Limited has informed the Exchange about Closure of Trading Window
  • Camlin Fine Sciences - Trading Window

    26 Mar 2025, 12:39PM Camlin Fine Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulati
  • Camlin Fine Sciences - Copy of Newspaper Publication

    25 Mar 2025, 3:14PM Camlin Fine Sciences Limited has informed the Exchange about Copy of Newspaper Publication
  • Camlin Fine Sciences - Notice Of Shareholders Meetings-XBRL

    24 Mar 2025, 7:44PM Camlin Fine Sciences Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot
  • Camlin Fine Sciences - Shareholders meeting

    24 Mar 2025, 6:54PM Camlin Fine Sciences Limited has informed the Exchange regarding Notice of Postal Ballot
  • Camlin Fine Sciences - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    24 Mar 2025, 6:49PM Notice of Postal Ballot
  • Camlin Fine Sciences - Updates

    18 Mar 2025, 4:44PM Camlin Fine Sciences Limited has informed the Exchange regarding 'Update on Analyst / Institutional Investor Meeting scheduled on March 18, 2025'.
  • Camlin Fine Sciences - Update On Analyst / Institutional Investor Meeting

    18 Mar 2025, 4:41PM Update on Analyst / Institutional Investor Meeting scheduled on March 18, 2025.
  • Camlin Fine Sciences - Updates

    13 Mar 2025, 10:40PM Camlin Fine Sciences Limited has informed the Exchange regarding 'Joint Press Release'.
  • Camlin Fine Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Mar 2025, 6:09PM Camlin Fine Sciences Limited has informed the Exchange about Schedule of meet
  • Camlin Fine Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 Mar 2025, 6:06PM Revised Schedule of Investor Meet
  • Camlin Fine Sciences - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    12 Mar 2025, 5:23PM CAMLIN FINE SCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfe
  • Camlin Fine Sciences - Appointment

    12 Mar 2025, 5:23PM Camlin Fine Sciences Limited has informed the Exchange regarding Appointment of Ms Radhika Dudhat as Non- Executive Independent Director of the compan
  • Camlin Fine Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Mar 2025, 3:23PM Camlin Fine Sciences Limited has informed the Exchange about Schedule of meet
  • Camlin Fine Sciences - Announcement under Regulation 30 (LODR)-Change in Management

    12 Mar 2025, 5:15PM Appointment of Additional Non-Executive Independent Director and Additional Non-Executive Non-Independent Director of the Company.
  • Camlin Fine Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 Mar 2025, 3:20PM Schedule of Investor Meet
  • Camlin Fine Sciences - Updates

    25 Feb 2025, 5:48PM Camlin Fine Sciences Limited has informed the Exchange regarding 'Updates on Press Release'.
  • Camlin Fine Sciences - Acquisition-XBRL

    25 Feb 2025, 12:02AM Camlin Fine Sciences Limited has informed the Exchange regarding Acquisition
  • Camlin Fine Sciences - Update On Press Release

    25 Feb 2025, 5:49PM Update on Press Release
  • Camlin Fine Sciences - Disclosure Pursuant To Clause 5 Of Para B Of Part A Of Schedule III Of SEBI LODR Regulations 2015\r\n

    24 Feb 2025, 11:57PM Disclosure Pursuant to Clause 5 of Para B of Part A of Schedule III of SEBI LODR Regulations 2015
  • Camlin Fine Sciences - Agreements

    24 Feb 2025, 11:53PM Camlin Fine Sciences Limited has informed the Exchange about Agreements
  • Camlin Fine Sciences - Announcement under Regulation 30 (LODR)-Acquisition

    24 Feb 2025, 11:50PM Acquisition of Vinpai S.A.
  • Camlin Fine Sciences - Acquisition

    24 Feb 2025, 11:50PM Camlin Fine Sciences Limited has informed the Exchange about Acquisition
  • Camlin Fine gains on Belgium acquisition

    12 Jun 2024 , 3:23PM The company’s wholly owned subsidiary, shall acquire 100% stake in Vitafor, at a consideration aggregating to € 1
  • Camlin Fine Sciences

    26 Jun 2020 , 11:18AM The company has stated that the Board has approved raising of Rs 180 crore from Infinity holdings and its affiliated entities through issuance of equity warrants based on the prevailing market price. The investment will result in nearly 22.65% ownership stake on a fully diluted basis. The objective of the fund raising is to consolidate and acquire the entire stake of its JV partners in the company's subsidiaries in Mexico and China.
  • Camlin Fine Sciences

    25 Feb 2020 , 2:08PM The company has stated that its China joint venture’s manufacturing facility has resumed operations – sentimentally positive read through
  • Camlin Fine Sciences

    11 Feb 2020 , 11:00AM The company stated that it is awaiting clearance from the Chinese Government to start its manufacturing facility in Zhejiang. The delay in resume the operations at the facility is owing to Government’s direction to not open facilities in the afore-mentioned province due to the outbreak of corona-virus – negative read through owing to loss of production and under absorption of fixed overhead for the slated period of closure.
  • Camlin Fine Sciences

    1 Feb 2020 , 10:01AM The company has stated that its Chinese Joint Venture manufacturing facility was earlier expected to restart operations from 2nd Feburary which now stands deferred 10th Feburary. This has been done as the China government has directed all industries operating in Zhejiang province to reopen from 9th Feburary to control pneumonia outbreak – sentimentally negative as there will be production loss for such period and will take time for the operations to normalise
  • Camilin Fine enters into agreement with Lockheed Martin

    15 Nov 2017 , 2:48PM Camlin Fine enters into a preferred supply agreement with Lockheed Martin Advanced Energy Storage
  • Camlin Fine Sciences enters preferred long term supply agreement

    15 Nov 2017 , 8:59AM Positive for Camlin Fine Sciences; however, details not available but stock to react positively and this could be game changing event for Camlin Fine Chem.
  • Camlin acquires 51% stake in Chinese company

    12 Jul 2017 , 10:22AM Camlin Fine Sciences along with its subsidiary has acquire 51% stake in a Chinese company.

Key fundamentals

Evaluate the intrinsic value of Camlin Fine Sciences Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 1207.3379 1246.4813 1040.0026 837.5762 708.1839
Liabilities 1207.3379 1246.4813 1040.0026 837.5762 708.1839
Equity 16.7465 15.7093 15.6984 12.7498 12.1254
Gross Profit 27.1294 127.5576 77.4823 61.8726 59.7128
Net Profit -51.3892 47.5547 25.8698 8.2812 30.7213
Cash From Operating Activities 82.1027 18.5248 46.7955 26.0217 73.8953
NPM(%) -6.64 6.02 3.77 1.38 5.29
Revenue 773.2621 789.4357 685.5081 600.0483 579.779
Expenses 746.1327 661.8781 608.0258 538.1757 520.0662
ROE(%) -5.61 5.2 2.82 0.9 3.35

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
28 Jul 2016 0.45 45 0 94
27 Jul 2015 0.45 45 0 85.5

Peers

Other companies within the same industry or sector that are comparable to Camlin Fine Sciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 631.20 2.44 18.71 1752.98 337.37 1.43
Amines and Plasticizers Ltd 220.88 0.54 29.53 1069.04 361.94 0.23
Grauer and Weil (India) Ltd 115.60 0.00 32.66 4404.90 322.62 0.43
HP Adhesives Ltd 51.09 -1.37 25.67 1785.12 99.28 0.00

Company Info

Camlin Fine Chemicals Limited was originally incorporated on 30th November 1993 under the Companies Act, 1956 in the name of Camlicon Consultants Private Limited. The name of the Company was thereafter changed to Camlin Fine Chemicals Private Limited w.e.f. 1st June 2006. Thereafter the status of the Company was changed to public limited company w.e.f. 11th August 2006 with the name being Camlin Fine Chemicals Limited. The main object of the Company was altered w.e.f. 26th April 2006 to enable the Company to pursue business in Fine Chemicals. The Main Objects are set out hereunder: To research, develop improve, process, manufacture, import, export and deal in all kinds of chemicals including Fine chemicals and intermediates, bulk drugs and ingredients, food adhesives food supplements, anti-oxidants active pharmaceutical ingredients organic chemicals acids alkalies and other preparations formulations compounds and ingredients. 2009 - Camlin Fine Chemicals Ltd has informed that the Board of Directors of the Company at its meeting held on January 08, 2009, has appointed Mr. Bhargav Patel as an Additional Director. --Registered Office of the Company has been shifted from ICC Chamber, 3rd Floor, Saki Vihar Road, Powai, Mumbai-400072 to Plot No. F/11 & F/12, Wicel, Opp. Seepz Main Gate, Andheri East, Mumbai-400093. 2010 -Camlin Fine Sciences Ltd Issues Rights in the Ratio of 3:5 2011 -Company has changed its name from Camlin Fine Chemicals Ltd. to Camlin Fine Sciences Ltd. 2012 -Company has splits its Face value of Shares from Rs 10 to Rs 2. 2013 - Board recommended a Dividend of Rs.0.60 Per Share (i.e. 30%) . 2014 - Board recommended a Dividend of Rs.0.70 Per Share of Rs. 2 each. -Camlin Fine Sciences has splits its face value from Rs 2/- to 1/- 2015 -Camlin Fine Sciences gets board nod to set up JV in USA 2016 -Camlin Fine to acquire 51% stake in Chinese firm 2020 -Commencement Of Commercial Production At The Company'S Manufacturing Unit Situated At Dahej, Gujarat. 2023 -Commencement of commercial production at the Company's Composite Vanillin manufacturing unit situated at Dahej, District Bharuch, Gujarat.

Camlin Fine Chemicals Limited was originally incorporated on 30th November 1993 under the Companies Act, 1956 in the name of Camlicon Consultants Private Limited. The name of the Company was thereafter changed to Camlin Fine Chemicals Private Limited w.e.f. 1st June 2006. Thereafter the status of the Company was changed to public limited company w.e.f. 11th August 2006 with the name being Camlin Fine Chemicals Limited. The main object of the Company was altered w.e.f. 26th April 2006 to enable the Company to pursue business in Fine Chemicals. The Main Objects are set out hereunder: To research, develop improve, process, manufacture, import, export and deal in all kinds of chemicals including Fine chemicals and intermediates, bulk drugs and ingredients, food adhesives food supplements, anti-oxidants active pharmaceutical ingredients organic chemicals acids alkalies and other preparations formulations compounds and ingredients. 2009 - Camlin Fine Chemicals Ltd has informed that the Board of Directors of the Company at its meeting held on January 08, 2009, has appointed Mr. Bhargav Patel as an Additional Director. --Registered Office of the Company has been shifted from ICC Chamber, 3rd Floor, Saki Vihar Road, Powai, Mumbai-400072 to Plot No. F/11 & F/12, Wicel, Opp. Seepz Main Gate, Andheri East, Mumbai-400093. 2010 -Camlin Fine Sciences Ltd Issues Rights in the Ratio of 3:5 2011 -Company has changed its name from Camlin Fine Chemicals Ltd. to Camlin Fine Sciences Ltd. 2012 -Company has splits its Face value of Shares from Rs 10 to Rs 2. 2013 - Board recommended a Dividend of Rs.0.60 Per Share (i.e. 30%) . 2014 - Board recommended a Dividend of Rs.0.70 Per Share of Rs. 2 each. -Camlin Fine Sciences has splits its face value from Rs 2/- to 1/- 2015 -Camlin Fine Sciences gets board nod to set up JV in USA 2016 -Camlin Fine to acquire 51% stake in Chinese firm 2020 -Commencement Of Commercial Production At The Company'S Manufacturing Unit Situated At Dahej, Gujarat. 2023 -Commencement of commercial production at the Company's Composite Vanillin manufacturing unit situated at Dahej, District Bharuch, Gujarat.

Read More

Parent Organisation

Camlin Fine Sciences Ltd.

Founded

30/11/1993

Managing Director

Mr.Nirmal Momaya

NSE Symbol

CAMLINFINEEQ

FAQ

The current price of Camlin Fine Sciences Ltd is ₹ 192.77.

The 52-week high for Camlin Fine Sciences Ltd is ₹ 197.15 and the 52-week low is ₹ 192.00.

The market capitalization of Camlin Fine Sciences Ltd is currently ₹ 3622.56. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Camlin Fine Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Camlin Fine Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Camlin Fine Sciences Ltd shares.

The CEO of Camlin Fine Sciences Ltd is Mr.Nirmal Momaya, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT